Inari Medical. has filed a patent for systems and methods for intravascular clot treatment in patients. The method involves using catheters to aspirate clot material and blood, filter the clot material, and reintroduce filtered blood back into the vasculature. The technology aims to improve clot removal processes. GlobalData’s report on Inari Medical gives a 360-degree view of the company including its patenting strategy. Buy the report here.
According to GlobalData’s company profile on Inari Medical, Customized implants was a key innovation area identified from patents. Inari Medical's grant share as of January 2024 was 32%. Grant share is based on the ratio of number of grants to total number of patents.
Intravascular clot treatment method using catheters and pressure source
A newly filed patent (Publication Number: US20230390045A1) outlines a method for treating clot material within a patient's vasculature. The method involves positioning a catheter near the clot, aspirating the clot material and blood into a clot container with a filter, and then using a pressure source to draw the filtered blood into the container. The filtered blood is then driven through a second catheter back into the vasculature. Additional steps include decoupling the clot container from the catheter before activating the pressure source, using a syringe as the pressure source, and removing the filter from the clot container to clear the clot material.
Furthermore, the method includes selectively providing fluid access to the catheter via a hemostasis valve, which can be controlled by adjusting the tension on a filament. The clot container is fluidically coupled to the catheter through a fluid control device that allows for the aspiration of clot material and blood. The patent also describes using an electric pump as the aspiration source, ensuring the clot container has a larger volume than the aspiration source, and utilizing user-actuatable valves for fluid control. Overall, this patent presents a detailed method for effectively treating clot material within a patient's vasculature, offering a comprehensive approach to managing this medical condition.
To know more about GlobalData’s detailed insights on Inari Medical, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.